Nine Chapters Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-77,891
Closed -$2.32M 406
2015
Q3
$2.32M Buy
77,891
+21,607
+38% +$693K 0.2% 131
2015
Q2
$1.79M Buy
+56,284
New +$1.83M 0.15% 189
2014
Q4
Sell
-177,704
Closed -$4.99M 1111
2014
Q3
$4.99M Sell
177,704
-34,888
-16% -$979K 0.44% 42
2014
Q2
$5.99M Buy
212,592
+203,001
+2,117% +$5.79M 0.49% 32
2014
Q1
$292K Sell
9,591
-372,800
-97% -$11.1M 0.03% 617
2013
Q4
$11.1M Buy
+382,391
New +$11.1M 1.12% 2
2013
Q3
Sell
-26,772
Closed -$711K 871
2013
Q2
$711K Buy
+26,772
New +$740K 0.12% 259

Other funds holding PFE

Nine Chapters Capital Management's PFE Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Pfizer (PFE) in Q4 2015, closing a stake of 77,891 shares — an estimated $2.32M sold.

Nine Chapters Capital Management first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $11.1M in Q4 2013. 1,969 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

  • Nine Chapters Capital Management reported no remaining Pfizer position as of Q4 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 77,891 Pfizer shares in Q4 2015, an estimated $2.32M.
  • Nine Chapters Capital Management first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
  • Nine Chapters Capital Management's Pfizer position peaked at $11.1M in Q4 2013.
  • 1,969 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.